GEHC GE HealthCare Technologies Inc.
Healthcare$64.18-0.08%ClosedMarket Cap: $29.19B
As of 2026-05-26
Valuation
P/E (TTM)
19.85
PEG
—
P/B
2.75
P/S
1.46
EV/EBITDA
11.83
DCF Value
$159.86
FCF Yield
5.2%
Div Yield
0.2%
Margins & Returns
Gross Margin
42.5%
Operating Margin
12.5%
Net Margin
7.5%
ROE
14.8%
ROA
4.1%
ROIC
6.7%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $5.13B | 38.5% | $515.0M | $389.0M | $— | $0.04 |
| Q4 null | $4.67B | 54.3% | $664.0M | $184.0M | $— | $0.04 |
| FY null | $20.63B | 40.0% | $2.76B | $2.08B | $— | $0.14 |
| Q3 null | $5.14B | 38.7% | $653.0M | $446.0M | $— | $0.04 |
| Q2 null | $5.01B | 39.7% | $654.0M | $486.0M | $— | $0.04 |
| Q1 null | $4.78B | 42.1% | $629.0M | $564.0M | $— | $0.04 |
| Q4 null | $5.32B | 42.8% | $801.0M | $720.0M | $— | $0.03 |
| FY null | $19.67B | 41.7% | $2.63B | $1.99B | $— | $0.12 |
| Q3 null | $4.86B | 41.7% | $676.0M | $471.0M | $— | $0.03 |
| Q2 null | $4.84B | 41.4% | $608.0M | $428.0M | $— | $0.03 |
| Q1 null | $4.65B | 40.9% | $540.0M | $374.0M | $— | $0.03 |
| Q4 2023 | $5.21B | 41.4% | $689.0M | $403.0M | $0.88 | $0.03 |